Life Sciences / Companies

3E Bioventures

3E Bioventures Capital is a life-sciences focused venture capital fund that invests in global health innovators. The firm targets Biotech (new drugs, new modalities, drug-discovery platforms) and TechBio (the intersection of biology and technology). 3E describes a science-driven, entrepreneur-friendly investment approach and partners with companies and research institutions to develop drugs or products addressing unmet medical needs. The firm’s motto is 3E: Expertise, Efficiency, Execution.

3E Bioventures

Beijing, Beijing, China, Asia

https://www.3ebiovc.com/

Services

Equity investment / capital

Provides investment capital to life-science and health-technology companies (Biotech and TechBio).

Scientific and product development collaboration

Works closely with companies and research institutions to develop drugs or products with strong unmet medical need.

Entrepreneur-friendly investment support

Provides an entrepreneur-friendly investing approach intended to support company founders and management.

Portfolio

Aravive

Developing an AXL-Fc fusion biologic that acts as a trap for Gas6-AXL signaling involved in tumor metastasis and EMT mechanisms.

#Biotech / New Drugs

OncoImmune

Developing a first-in-class biologic drug targeting CD24–Siglec innate immunity signaling.

#Biotech / New Drugs

C4 Therapeutics

Developing small-molecule drugs that selectively degrade disease-causing proteins using the cell's innate degradation machinery.

#Biotech / New Drugs

Cognition Therapeutics

Targets cellular damage response mechanisms to treat central nervous system disorders.

#Biotech / New Drugs

OncoC4

Clinical-stage immuno-oncology company developing CTLA-4 and CD24 antibodies; founded by immunologist Prof. Yang Liu.

#Biotech / New Drugs

Quadriga

Developing a first-in-class small-molecule drug targeting LAT1, a large amino-acid transporter protein.

#Biotech / New Drugs

Avirmax

Developing a next-generation gene-therapy drug-delivery platform initially targeting chronic eye diseases.

#Biotech / New Drugs

Cullgen

Using targeted protein degradation technology to create drugs for diseases lacking effective therapies.

#Biotech / New Drugs

SHANTON

Research organization focusing on uric acid metabolism, inflammatory pain, gout, and metabolic-syndrome-related diseases.

#Biotech / New Drugs

Rapafusyn

Platform based on proprietary libraries of FKBP-binding bi-functional macrocycles (rapafucins).

#Biotech / New Drugs

Dewpoint Therapeutics

Translates condensate biology into therapeutic programs.

#Biotech / New Drugs

Dermaliq

Pharmaceutical company focused on dermatology; spin-off from Novaliq GmbH (founded 2021).

#Biotech / New Drugs

Myro Therapeutics

Develops small-molecule therapeutics aiming to restore brain health by targeting common disease mechanisms.

#Biotech / New Drugs

Retex Pharmaceuticals

Working to develop a cure for ADPKD (autosomal dominant polycystic kidney disease) patients.

#Biotech / New Drugs

Exarta Therapeutics

Described as focused on ferroptosis-related biology ('The Ferroptosis Company').

#Biotech / New Drugs

Larkspur

Targets intersections for precision immunotherapy, especially antigen presentation.

#Biotech / New Drugs

Cytek

Developing a new flow cytometer platform replacing traditional filters with optical grating and PMTs with APDs.

#X-Disciplinary HealthTech

Twist Bioscience

Silicon-based platform for high-throughput, rapid, precise and cost-effective DNA synthesis applicable across healthcare and other fields.

#X-Disciplinary HealthTech

Neural Galaxy

Founded out of Harvard Medical School and MIT McGovern Institute; focused on brain-disorder solutions.

#X-Disciplinary HealthTech

NanoInsights-Tech

Super-resolution microscopic imaging platform originating from a Nobel Prize winner’s laboratory.

#X-Disciplinary HealthTech

Eluminex

Described as innovative ocular therapeutics for China and global markets.

#X-Disciplinary HealthTech

Eaglenos

Focused on personalized health management through precision measurements and technology innovation.

#X-Disciplinary HealthTech

Profusa

Developing a biosensor platform for non-invasive continuous blood-chemistry monitoring (O2, glucose, pH, lactate, etc.).

#X-Disciplinary HealthTech

Kolo

MEMS-based CMUT semiconductor ultrasound technology aiming for higher resolution and reduced cost.

#X-Disciplinary HealthTech

Genotix

Digital ELISA protein-detection platform with high sensitivity, throughput and dynamic range.

#X-Disciplinary HealthTech

Subtle Medical

Provides FDA-cleared AI solutions for medical imaging enhancement.

#X-Disciplinary HealthTech

Smartlens

Platform company aiming to prevent blindness from glaucoma and address challenges in glaucoma management.

#X-Disciplinary HealthTech

Acclaro

MID-IR fiber-laser medical aesthetic platform.

#X-Disciplinary HealthTech

View All Portfolio Items